EcoDrugPlus

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSKMAG00000015783
Gene Symbol: LOC108228424
2 Cross references
232 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSKMAG00000002716
Gene Symbol: LOC108229377
3 Cross references
230 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSKMAG00000010150
Gene Symbol: GSK3A
3 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSKMAG00000021905
Gene Symbol: GSK3B
3 Cross references
222 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSKMAG00000010656
Gene Symbol: LOC108249892
3 Cross references
187 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSKMAG00000019968
Gene Symbol: LOC108250188
2 Cross references
155 Possible Orthologues:

Granzyme B(G,h)-Like

Ensembl ID : ENSKMAG00000004832
Gene Symbol: LOC108230697
2 Cross references
962 Possible Orthologues:

Granzyme B-Like

Ensembl ID : ENSKMAG00000004915
Gene Symbol: LOC108230715
2 Cross references
967 Possible Orthologues:

Granzyme E-Like

Ensembl ID : ENSKMAG00000004867
Gene Symbol: LOC108230712
2 Cross references
958 Possible Orthologues:

Granzyme G-Like

Ensembl ID : ENSKMAG00000004887
Gene Symbol: LOC108230705
2 Cross references
958 Possible Orthologues:

Granzyme-Like Protein 2

Ensembl ID : ENSKMAG00000004759
Gene Symbol: LOC112450232
2 Cross references
954 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSKMAG00000001309
Gene Symbol: GHRHR
4 Cross references
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).